NITROGLYCERIN HAS BEEN USED in the treatment of angina pectoris for longer than a century. Recently, however, many clinical and experimental studies have suggested that the agent may be beneficial in the treatment of left ventricular failure due to both acute myocardial infarction1-8 and chronic ischemic heart disease.9"'5 These studies have shown that nitroglycerin causes a reduction in left ventricular filling pressure, a decline in arterial pressure of varying degree (depending on route and speed of drug administration), variable changes in cardiac output, and in many of the studies, evidence of improved performance of areas of ischemic left ventricular dysfunction. The mechanism for these changes is not known, but has been attributed to increased venous capacitance, afterload reduction and favorable effects on myocardial oxygen supply/demand ratio.
Our study was designed to test whether nitroglycerin directly affects segmental myocardial performance in a canine myocardial ischemia preparation. Performance was assessed by examining left ventricular systolic and diastolic wall thickness using ultrasound techniques during transient occlusion of the left anterior descending coronary artery. The results show that ischemic segment dysfunction is not affected by nitroglycerin, and suggest that improved overall left ventricular performance in this preparation is the result of the peripheral vascular effects of the agent.
Materials and Methods
The study was performed using 24 mongrel dogs weighing 21.5 ± 0.9 kg (SEM). The animals were anesthetized with a mixture of chloralose 30 mg/kg and urethane 450 mg/kg intravenously, after premedication with morphine sulphate 3 mg/kg given subcutaneously. One hour later, a second dose of morphine (1.5 mg/kg) was injected subcutaneously. The animals were ventilated using a 40% oxygen-air mixture through a Bennett respirator. A #9 NIH catheter was introduced through the femoral artery into the ascending aorta for continuous measurement of central aortic pressure, and a #18 intracath was inserted into a left foreleg vein to permit infusion of nitroglycerin. A left thoracotomy was performed with exposure of the pericardium to form a cradle for the heart. A 10-cm long PE 240 catheter was introduced into the left ventricular cavity through the apical dimple. Pressures were obtained using Statham P23Db transducers.* This system had a natural frequency of 70 Hz.
Ultrasound measurements were made using a standard instrument.t A short-focus 3.5-mHz pediatric cardiac echotransducert with a flat face 6 mm in diameter was modified to measure left ventricular anterior wall thickness. The transducer was fitted into an acrylic barrel 5 cm long, with the surface of the transducer face fixed 3 cm from the open end of the barrel, which was filled with gel. § Taking care to remove all air bubbles, the open end of the barrel was sealed using a thin plastic film. To obtain measurements, the plastic barrel with the transducer was manually positioned perpendicular to and in contact with the epicardial surface of the heart. This system allowed coupling of the transducer to the surface of the myocardium via the flexible and closely-fitting interface provided by the plastic film. With this system, the epicardial surface appears on tracings as a straight line, since the acrylic barrel is in steady contact with the epicardium throughout the cardiac cycle, and the distance between the transducer face and the surface of the left ventricle remains constant. The echocardiographic transducer was calibrated for depth measurements and found to be linear. The measured distance between the transducer face and the membrane covering the plastic barrel (3 cm) was verified on recordings made during the calibration procedure, and the exact position of the membrane was also recorded at intervals throughout the procedure to permit precise identification of the epicardium.
Coronary ischemia was produced by snaring the mid-left anterior descending coronary artery. During a temporary 30-second occlusion, areas for transducer placement and recording of echocardiograms were identified. Proceeding from the center of the ischemic zone upward and laterally toward the atrioventricular groove, the center of the ischemic area was marked with an indelible pen, and identified as zone 1, the border of the cyanotic ischemic area as zone 2, the adjacent inner rim of normal noncyanotic myocardium as zone 3, and the distant normal myocardium as zone 4 ( fig. 1 ). In 13 of the 24 animals, an additional measurement was made by positioning the transducer between zone 2 and zone 3, i.e., directly over the area of transition between cyanotic and noncyanotic myocardium (zone 2a, fig. 1 ). This technique allowed exact repositioning of the transducer over the directly *Statham Instruments Co., Inc visualized area of interest at each phase of the protocol. During the experiment the ECG, the aortic, and left ventricular pressures on high and low gain, left ventricular dP/dt, and echocardiograms of zones 1-4 were recorded at appropriate intervals, using a multichannel recorder.* Blood gases and pH, measured using a standard instrument,t and hematocrit, measured by the microcrit method, were evaluated at intervals throughout the experiment, and remained in the normal range.
In each experiment, after control measurements, transient coronary ischemia was produced for 5 minutes, and the recordings were repeated. We allowed 1 hour for recovery before performing a second control measurement. This was followed by an infusion or bolus injection of nitroglycerin. The nitroglycerin for intravenous infusion or bolus injection was prepared by dissolving 0.4 mg tablets in normal saline just before each administration in a concentration which permitted an infusion rate of 0.1 ml/kg/min. 
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VOL 59, No 5, MAY 1979 During the infusion studies, at the end of a 10-15minute infusion period, we again obtained hemodynamic data and echocardiographic tracings. This was followed immediately by a 5-minute period of transient coronary occlusion, during which all recordings were repeated. Thus, each experiment consisted of an initial control, followed by ischemia, followed by a recovery period, then a second control, followed by administration of nitroglycerin, followed by ischemia in the presence of nitroglycerin.
After completion of this protocol, another recovery period of 1 hour was allowed and the entire protocol was repeated using another dosage level of nitroglycerin. In most animals, two dosage levels of nitroglycerin were studied (n = 9), but in six animals three dosage levels were used, and in two animals only a single dose was administered. Thirty-eight nitroglycerin infusion studies were carried out in 17 dogs, using infusion rates of 2.5 ,ug/kg/min (n = 9, group 1), 5 ug/kg/min (n= 7, group 2), 10 ,ug/kg/min (n = 8, group 3), 20 ,ug/kg/min (n = 7, group 4), and 50 ,g/kg/min (n = 7, group 5).
Thirteen additional studies were carried out in seven dogs using nitroglycerin as a bolus injection of 20 ptg/kg (n = 6, group 6) and 50 ,ug/kg (n = 7, group 7). For this protocol, two bolus injections of nitroglycerin were used. After the initial bolus, a 20-minute recovery period was allowed. Then the left anterior descending coronary artery was occluded for 4 minutes, and a second bolus of nitroglycerin administered. Hemodynamic and wall thickness measurements were made approximately 45 seconds after the bolus injections, at the nadir of the decline in aortic pressure.
In the nitroglycerin infusion study (n = 38, groups 1-5), we noted in eight instances that heart rate during nitroglycerin plus ischemia was either the same as or lower than the heart rate during ischemia alone. The data from these eight studies were analyzed separately to evaluate the interaction between nitroglycerin and ischemia in the absence of tachycardia.
For echocardiographic measurements, left ventricular wall thickness in zones 1-4 was measured to the nearest 0.5 mm as the distance from endocardium to epicardium at end-diastole, timed at the Q wave of the ECG, and at end-systole, timed by the peak negative deflection of the dP/dt tracing. For consistency, thickness measurements were made between the lower edges of the upper and lower lines representing epicardium and endocardium, respectively ( fig. 2 ), and the gain of the system, once set, was not changed during an experiment. Percent increase in wall thickness in systole, or percent systolic wall thickening (%SWT) was calculated as:
%SWT systolic wall thickness -end-diastolic wall thickness X 100 end-diastolic wall thickness In addition, all wall thickness data were normalized to the end-diastolic thickness in the initial control state by calculating all subsequent changes in thickness in systole or at end-diastole as a percentage of this value:
Normalized thickness value (%) observed thickness valueinitial end-diastolic wall thickness value initial end-diastolic wall thickness x 10 value This additional calculation minimizes the influence on thickness values of changes in end-diastolic wall thickness which occurred during the course of the experiment.
Statistical analysis was carried out within a group by paired t test and between groups by group t test.
Results

Coronary Occlusion With and Without Nitroglycerin Infusion
Hemodynamics
Hemodynamic data are given in table 1. Control values of heart rate, aortic mean and left ventricular end-diastolic pressures, and left ventricular dP/dt were comparable during the initial control state in groups 1-5. Coronary occlusion resulted in an increase in heart rate and left ventricular end-diastolic pressure in every group, but there was no consistent alteration in aortic mean pressure or left ventricular dP/dt. After the 1-hour recovery period, control measurements had returned to baseline, with one exception in group 2, in which aortic mean and left ventricular end-diastolic pressures were significantly lower than the initial control. Nitroglycerin resulted in an increase in heart rate in all groups, ranging from 21-55%, and a significant decline in left ventricular end-diastolic pressure in three of the five groups. However, aortic mean pressure showed only a modest decline, in the range of 4-9 mm Hg, and this was significant in only two of the five groups. Linear and logarithmic regression analysis for dose dependency of changes in heart rate, aortic mean and left ventricular end-diastolic pressure and left ventricular dP/dt over the entire range of infusion rates of nitroglycerin from 2.5-50 ,ug/kg/min revealed no significant relationship between dosage and observed hemodynamic changes. The hemodynamic effects of ischemia induced during nitroglycerin infusion, when compared with ischemia alone, revealed significantly lesser elevations in left ventricular end-diastolic pressure in all groups. Aortic mean pressure was also lower and heart rate more rapid during ischemia in the nitroglycerin treated groups, but these changes were significant only in groups 3-5 and groups 4 and 5, respectively.
Wall Thickness
Wall thickness data are given in tables 1 and 2 and figures 2 and 3. Wall thickness measurements and percent systolic wall thickening at specific zones were 928 CIRCULATION NITROGLYCERIN IN ACUTE ISCHEMIA/Komer et al.
ZONE I
Representative echocardiographic tracings from zones 1, 2 and 3 during the controlperiod, ischemia, second control and nitroglycerin (NTG) plus ischemia. Note the presence ofdiastolic thinning and a marked decrease in systolic thickening during ischemia and during NTG plus ischemia in zone 1, return to baseline during the second control, and reappearance of contraction abnormalities during NTG plus ischemia. Similar abnormalities, but of lesser degree, are present during ischemia and NTG plus ischemia in zone 2. The contraction pattern in zone 3 remains normal throughout. similar in groups 1-5 during the initial control state. Zone 1. In groups 1-5 the mean values of wall thickness in the control state ranged from 5.9 -7.7 mm in end-diastole and 11.1-13.4 mm at end-systole, a mean increase for all five groups of 82% in wall thickness during systole. During coronary ischemia, the mean diastolic wall thickness decreased by 18% and systolic wall thickness by 52%, and the mean percent systolic thickening decreased from 82% to 8%. In 71 % of the observations made during ischemia, the maximum wall thickness was noted to be in early diastole, at the time of the early diastolic dip in the left ventricular pressure tracing. After coronary reperfusion there was a rapid return to a normal contraction pattern, and at the end of the 1-hour recovery period there were no significant differences from the original control.
Nitroglycerin did not cause any significant change in wall thickness values except for the isolated finding of decreased systolic thickening in group 4. Induction of ischemia during nitroglycerin infusion resulted in wall thickness changes similar to those produced by ischemia alone, except for larger values of diastolic wall thickness, which were significant in groups 3 and 5. The mean percent systolic wall thickening, which was 8% during the initial episode of ischemia, was significantly reduced to -3% during nitroglycerin plus ischemia, but this may be attributed to the larger values of diastolic wall thickness in the latter state. In 97% of the observations made during ischemia, the maximum wall thickness was noted to be in early diastole ( fig. 4 ).
Zone 2. Ischemia produced changes similar to those noted in zone 1, but lesser in magnitude (table 1, figs. 2 and 3). During ischemia, mean diastolic wall thickness decreased by 9%, systolic wall thickness by 41%, and mean percent systolic wall thickening from 85% to 20%. Maximum wall thickness in early diastole was observed in 64% of instances. As in zone 1, a normal contraction pattern was restored after coronary reperfusion. Nitroglycerin did not cause any significant changes in wall thickness measurements. Ischemia induced during nitroglycerin infusion produced results similar to those noted during ischemia alone, except for a trend toward increased diastolic wall thickness, which was significant in groups 2 and 5. Specifically, there was no significant difference in mean percent systolic wall thickening in the two states (20% vs 13%, respectively).
Zone 2a. Wall thickness measurements in the area intermediate between zones 2 and 3 were made in 16 experiments in which nitroglycerin infusion was used (table 2, fig. 3 ). With the initial occlusion changes intermediate between zones 2 and 3 were noted. There were no significant changes in diastolic wall thickness, but mean systolic wall thickness decreased by 15%, and mean percent systolic wall thickening decreased from 91% to 59%. As in zone 2, the contraction pattern returned to normal after reperfusion, nitroglycerin infusion produced no significant changes in wall thickness, and induction of ischemia during nitroglycerin infusion resulted in changes which were similar to those noted during the initial occlusion.
Zones 3 and 4. There were no consistent changes in diastolic or systolic wall thickness or percent systolic wall thickening among the various groups with coronary occlusion or nitroglycerin administration in zone 3 (table 1, figs. 2 and 3). The same was true for echocardiographic recordings from zone 4 (not shown). 
Coronary Occlusion With and Without Nitroglycerin Bolus Injection
Hemodynamics
Hemodynamic data are given in table 3. Initial coronary occlusion resulted in an increase in heart rate and left ventricular end-diastolic pressure in both groups, but aortic mean pressure and left ventricular dP/dt did not change significantly.
After the 1-hour recovery period, measurements had returned to baseline. The initial bolus injections of nitroglycerin of 20 and 50 A.tg/kg resulted in increase in heart rate of 62% and 73%, and decreases in aortic mean pressure of 25% and 31%, in groups 6 and 7, respectively; this degree of tachycardia and hypotension was significantly greater than that produced by constant infusions of nitroglycerin at the rate of 20 and 50 ,ug/kg/min (groups 4 and 5, in both groups 6 and 7, and increased left ventricular dP/dt in group 7 only (table 3) .
The second bolus injections of nitroglycerin, given after induction of ischemia, resulted in hemodynamic changes comparable to the initial bolus. However, compared with the initial episode of ischemia, heart rate was more rapid, aortic mean pressure and left ventricular end-diastolic pressure were reduced (groups 6 and 7), and left ventricular dP/dt was increased (group 7).
Wall Thickness
Wall thickness measurements and percent systolic wall thickening in specific zones during the initial control state (table 3) were comparable to the observations made in groups 1-5 (table 1). During the initial episode of coronary occlusion, changes comparable to those observed in groups 1-5 were noted in zones 1 and 2, with end-diastolic thinning and loss of systolic thickening. There was less striking impairment of systolic thickening in zone 2a, and zones 3 and 4 (the latter not shown) were unaffected (table 3) . Again, recovery was complete after reperfusion. As in groups 1-5, nitroglycerin administration produced no significant effects, and a second bolus injection of nitroglycerin during ischemia produced no significant changes in wall thickness compared with the initial episode of ischemia.
Other Observations
Because of the possibility that nitroglycerin-induced sinus tachycardia might have deleterious effects on 931 VOL 59, No 5, MAY 1979 mechanical performance of ischemic myocardium, we analyzed separately a subgroup of experiments from groups 1-5 in which heart rate during nitroglycerin infusion plus ischemia was equal to or lower than that during the initial ischemic event. Of the 38 nitroglycerin infusion studies, eight fell into this category (table 4). Hemodynamic measurements during the initial control state, during the initial episode of ischemia, during recovery, and during nitroglycerin infusion were similar to those noted in the entire group (table 1). The same was true of hemodynamic changes noted during nitroglycerin infusion plus ischemia, except for the significantly lower heart rate.
A comparison of wall thickness changes in zones 1-4 in this subgroup of experiments also revealed changes comparable to those occurring in the entire group. There was end-diastolic wall thinning in zones 1 and 2, virtual abolition of systolic thickening in zone 1, and attenuation of systolic wall thickening in zone 2, with percent systolic wall thickening being 30% during the initial ischemic event, and 24% during nitroglycerin infusion plus ischemia. Zones 3 and 4 (the latter not tabulated) showed no consistent changes.
Discussion
Changes in myocardial wall thickness have been shown to reflect regional myocardial performance."' Myocardial wall thickness has been measured by mechanical,'7' 18 radiographic'2' 19-22 and ultrasonic techniques.'6' 23 The percentage of left ventricular myocardial wall systolic thickening typically ranges from 10-30% when measured from markers or transducers located transmurally in fixed positions, and from 40-120%, in the same range noted in the present study, using angiographic or standard echocardiographic techniques. The lower values obtained by mechanical methods may be due to interference by the implanted device. Conversely, the higher values obtained by angiography or by standard echocardiography may result from some infolding of myocardium at the endocardial surface, as described by Mitchell and co-workers.20 Standard echocardiography has previously been used in patients to evaluate dynamic posterior wall thickness, velocity and excursion.23' 24 Kerber and coworkers used similar methods to assess dysfunction in experimental posterior wall ischemia using a transducer positioned anteriorly over the right ventricle, and directed so that posterior wall motion was detected.25' 26 We chose to use standard echocardiographic techniques to measure anterior wall thickness immediately subadjacent to the transducer. This technique has the advantages of permitting repositioning of the transducer at preselected sites marked on the myocardial surface, and of assuring that tracings are obtained with the transducer normal to the cardiac surface, thus avoiding artifacts caused by oblique positioning. 27 In this study, we used a combination of anesthetics that maintains intact autonomic reflexes.28 29 Control state hemodynamics, and the effects of coronary occlusion, consisting of an increase in heart rate and in left ventricular end-diastolic pressure, were comparable to those noted in unanesthetized animals. 30 The degree of systolic wall thickening in the control state was also comparable to that measured by echocardiography in patients without ischemic heart disease. 23 With occlusion of the left anterior descending coronary artery, normal systolic wall thickening was attenuated or lost completely, with a graded degree of reduction from the center to the border zones of ischemia. End-diastolic thinning of the ischemic and border zones was also observed. These changes appear to be analogous to observations made by other investigators from length transducers placed transversely at an epicardial or intramyocardial locus. When coronary occlusion is produced, systolic shortening is lost, and is replaced by systolic aneurysmal bulging, and end-diastolic segment length is also increased.2' 8, 31, 32 Loss of systolic thickening or shortening is a measure of ischemia-induced reduction of performance by the affected segment, and end-diastolic thinning and lengthening presumably are due to the effects of both increase in end-diastolic pressure, and stress relaxation of the ischemic segments.3' The latter must play an important role in the present experiments, as end-diastolic thickness was not consistently affected in the control non-ischemic areas. The early diastolic thickening which was so prominent in some of the echocardiographic tracings ( fig. 4 ) has also been observed in segment length tracings in the form of late systolic or early diastolic shortening,8 though the phenomenon remains unexplained.
The hemodynamic effects of nitroglycerin in both the control state and after coronary occlusion in this preparation were similar to those reported in numerous previous experimental2' 3, 7, 8, 33 and clinical",4 6 studies. Nitroglycerin in the normal circulation causes a decrease in left ventricular filling pressure and aortic mean pressure, and an increase in heart rate. The pressure changes are the result of increased venous capacitance and arteriolar dilatation34 and the heart rate increase is of reflex origin.33 During slow administration of nitrates, effects upon venous capacitance may predominate,34 and ventricular filling pressures may decline, with minimal alteration in systemic vascular resistance;6 more rapid administration, as with bolus injections, may produce marked transient arteriolar dilatation and decline in arterial pressure. Such differences between the effects of nitroglycerin infusions and bolus injections were clearly noted in this investigation. Lack of dose dependency of hemodynamic or wall thickness changes with nitroglycerin administration was also a notable finding of the present study.
Despite the clearcut effects of nitroglycerin on systemic hemodynamics and heart rate in the present experiments, there was no effect on segmental function as assessed by echocardiographic wall thickness measurements. These findings must be reconciled with numerous other reports in the literature which indicate that, under some conditions, myocardial segments which display ischemic dysfunction may be improved by nitroglycerin administration. In anesthetized dogs, using epicardial strain gauges and length gauges3 or intramyocardial ultrasonic segment length transducers,2 intravenous bolus injections of nitroglycerin improved segmental shortening of the ischemic border zone, and in the latter experiments slightly improved central ischemic zone shortening as well. Similar results were obtained in awake dogs.8 Theroux and coworkers concluded that nitroglycerin administration did result in improved myocardial shortening in border zones of ischemia, but they could not determine whether these effects were directly the result of improved myocardial performance, or whether they represented passive alterations in myocardial motion due to diminished preload and afterload.2, 8 However, not all investigators have been able to confirm these findings; Lang and co-workers demonstrated that nitroglycerin infusion produced no improvement in segmental dysfunction in abnormal ventriculograms of anesthetized dogs with acute coronary occlusion. 7 No comparable observations regarding effects of nitroglycerin on regional myocardial performance are available in the acute phase of myocardial infarction in man, but several studies have been carried out in patients with chronic ischemic heart disease.9-18 These ventriculographic studies have shown that there is often improvement in previously impaired segmental motion after nitroglycerin. Several authors have noted that areas of hypokinesis appear to respond best, with areas of akinesis responding variably, and areas of dyskinesis not at all.", 12 The findings are similar to those in acute myocardial ischemia in dogs,2 3 8 in which border zones of intermediate myocardial dysfunction usually respond with increased systolic shortening, but central ischemic zones of more severe dysfunction respond less well or not at all.
In the present experiments, in contrast to those cited above, we found no improvement in ischemic wall thickness abnormalities in any location. Several possibilities might explain this discrepancy:
1) The standard echocardiographic technique used in this study might not display sufficient resolution to detect the anticipated changes. We arbitrarily measured echocardiographic wall thickness to the nearest 0.5 mm, approximately 6% of control enddiastolic wall thickness, while some of the techniques used in animals evidently will resolve length differences as small as 0.05 mm.2 In the present study we could detect significant differences in end-diastolic 934 CI RCULATION wall thickness during ischemia of 8-16%, representing actual changes in wall thickness in the range of 0.5-1.0 mm. It might be expected that similar changes in end-systolic thickness resulting from drug administration, if present, could be detected. The changes in border zone systolic shortening resulting from nitroglycerin administration in the studies of Theroux and co-workers were 66% in anesthetized dogs and 28% in unanesthetized dogs,2 8 in excess of the resolution of the echocardiographic system used in our study. Therefore, lack of resolution is probably not the problem.
2) Dynamic measurements of wall thickness might give different results from dynamic measurements of segment length,2 3 8 velocity of wall thickening,'2 or the various measurements of segmental function made from ventriculograms9 11, [13] [14] [15] with nitroglycerin administration. Differences between improved systolic shortening and unimproved systolic thickening in the acute experimental preparations might be explained by speculating that the former measurements could be affected by compressive forces from surrounding normal myocardium, and the latter might not be. However, lack of increased systolic thickening is more difficult to reconcile with ventriculographic findings in clinical chronic ischemic heart disease; improved segmental function and ejection fraction is a frequent finding during nitroglycerin administration in these studies, while we found no evidence of increased systolic thickening in any of the zones examined.
3) The responsiveness of myocardium to nitroglycerin might differ in acute and chronic ischemia.
Acutely ischemic myocardium can respond to direct inotropic stimulation,3and rapid recovery occurs with reperfusion under the conditions of the present study. Thus, there is no question about the viability of the segment under study, or its ability to respond to certain types of stimuli. In chronic ischemia, responsiveness to nitroglycerin might be related to the adequacy of collateral formation.9 Collaterals are sparse in acute ischemia, but more abundant in chronic ischemia, and it is also known that nitroglycerin may enhance collateral flow.36' 37 Thus, some of the discrepancies between effects of nitroglycerin in various phases of ischemia may be explained by timedependent changes in the characteristics of the ischemic segment. 4) Degree of responsiveness of ischemic segmental dysfunction might relate to the degree of unloading produced by nitroglycerin, in terms of reduction in preload and afterload. 2 8 In one clinical study, it was noted that failure of improvement in segmental dysfunction was correlated in some patients with absence of a nitroglycerin effect upon aortic and left ventricular pressure;15 however, in the report of Dumesnil et al.'2 a number of examples are presented of patients who showed marked improvement in depressed segmental function, in the absence of significant hemodynamic changes. In the present experiments, the degree of left ventricular failure was mild, and nitroglycerin produced only a small, although significant, decline in left ventricular enddiastolic pressure. Whether different effects might be observed if preload were markedly elevated in this preparation, and markedly reduced by nitroglycerin, is not known. So far as changes in aortic pressure are concerned, we observed no improvement in segmental thickening either in animals that showed only a slight decline in aortic pressure (nitroglycerin infusion) or in those with a marked drop in aortic pressure (nitroglycerin bolus injections).
Although clinical evidence of hemodynamic improvement in left ventricular failure often occurs with nitroglycerin administration in both acute myocardial infarction" -' and chronic myocardial ischemia,'0' 12-1' it is generally agreed that reflex tachycardia is potentially deleterious, since it increases myocardial oxygen requirements. Thus, administration of nitroglycerin to animals with coronary ischemia reduces the degree of ST-segment elevation, 935 
